OpenProtein.AI Expands Strategic Partnership with Boehringer Ingelheim to Advance AI-Driven Antibody Discovery

B Boehringer Ingelheim expands its collaboration with OpenProtein.AI following successful initial deployment, co-developing integrated workflows for next-generation therapeutic development. NEW YORK, March 31, 2026 /PRNewswire/…

posteditor
posteditor
Articles: 27298

Other News